Recombinant humanized anti-PD-1 monoclonal antibody (JS001) in patients with refractory/metastatic nasopharyngeal carcinoma: Preliminary results of an open-label phase II clinical study

Phase Ii ◽

Open Label ◽

Preliminary Results ◽

Open Label Phase ◽

Recombinant humanized anti-PD-1 monoclonal antibody toripalimab in patients with refractory/metastatic urothelial carcinoma: Preliminary results of an open-label phase II clinical study

European Urology Open Science ◽

10.1016/s2666-1683(20)33652-1 ◽

2020 ◽

Vol 19 ◽

pp. e1579

Author(s):

H. Chen ◽

X. Sheng ◽

R. Zhang ◽

B. Hu ◽

X. Yao ◽

...

Keyword(s):

Monoclonal Antibody ◽

Clinical Study ◽

Urothelial Carcinoma ◽

Phase Ii ◽

Open Label ◽

Preliminary Results ◽

Open Label Phase ◽

Phase Ii Clinical Study ◽

Metastatic Urothelial Carcinoma

Recombinant humanised anti-PD-1 monoclonal antibody (JS001) treatment for patients with refractory or metastatic nasopharyngeal carcinoma: preliminary results of an open-label, phase 1b/2, clinical study

The Lancet Oncology ◽

10.1016/s1470-2045(17)30757-x ◽

2017 ◽

Vol 18 ◽

pp. S1 ◽

Cited By ~ 2

Author(s):

Ruihua Xu ◽

Fenghua Wang ◽

Qi Li ◽

Jianhua Shi ◽

Lin Shen ◽

...

Keyword(s):

Monoclonal Antibody ◽

Clinical Study ◽

Open Label ◽

Preliminary Results ◽

Open Label Phase ◽

Phase 1B

An open-label, single-arm phase II clinical study of docetaxel plus lobaplatin for Chinese patients with pulmonary and hepatic metastasis of nasopharyngeal carcinoma

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000370 ◽

2016 ◽

Vol 27 (7) ◽

pp. 685-688 ◽

Cited By ~ 6

Author(s):

Shuai Zhang ◽

Junni Chen ◽

Shiping Yang ◽

Shaomin Lin

Keyword(s):

Clinical Study ◽

Phase Ii ◽

Hepatic Metastasis ◽

Chinese Patients ◽

Open Label ◽

Bevacizumab versus placebo in combination with paclitaxel and carboplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase II trial

ESMO Open ◽

10.1016/j.esmoop.2021.100313 ◽

2021 ◽

Vol 6 (6) ◽

pp. 100313

Author(s):

T. Zhou ◽

Y. Yang ◽

S. Ma ◽

L. Lin ◽

T. Zhou ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Open Label Phase ◽

First Line Treatment

First-line paclitaxel plus carboplatin with/without bevacizumab in recurrent or metastatic nasopharyngeal carcinoma: A multicenter, randomized, open-label, phase II trial

Annals of Oncology ◽

10.1093/annonc/mdx374.009 ◽

2017 ◽

Vol 28 ◽

pp. v376-v377

Author(s):

L. Zhang ◽

Y. Huang ◽

Y. Yang ◽

S. Ma ◽

X. Lin ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

Open Label ◽

Open Label Phase

Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC

Journal for ImmunoTherapy of Cancer ◽

10.1186/2051-1426-3-s2-p200 ◽

2015 ◽

Vol 3 (Suppl 2) ◽

pp. P200 ◽

Cited By ~ 4

Author(s):

Marina G Tarakanovskaya ◽

Jigjidsuren Chinburen ◽

Genden Purevsuren ◽

Chogsom Munkhzaya ◽

Purev Batchuluun ◽

...

Keyword(s):

Clinical Study ◽

Liver Cancer ◽

Phase Ii ◽

Open Label ◽

Advanced Hcc ◽

Open Label Phase ◽

Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial

Annals of Oncology ◽

10.1093/annonc/mdz020 ◽

2019 ◽

Vol 30 (4) ◽

pp. 637-643 ◽

Cited By ~ 13

Author(s):

C. Zhao ◽

J. Miao ◽

G. Shen ◽

J. Li ◽

M. Shi ◽

...

Keyword(s):

Clinical Trial ◽

Monoclonal Antibody ◽

Epidermal Growth Factor Receptor ◽

Growth Factor Receptor ◽

Radical Radiotherapy ◽

Open Label ◽

Open Label Phase ◽

Epidermal Growth

Capecitabine plus paclitaxel induction treatment in gastric cancer patients with liver metastasis: a prospective, uncontrolled, open-label Phase II clinical study

Future Oncology ◽

10.2217/fon-2016-0145 ◽

2016 ◽

Vol 12 (18) ◽

pp. 2107-2116 ◽

Cited By ~ 2

Author(s):

Ai-Wen Wu ◽

Peng Yuan ◽

Zi-Yu Li ◽

Lei Tang ◽

Zhao-De Bu ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Study ◽

Liver Metastasis ◽

Cancer Patients ◽

Phase Ii ◽

Induction Treatment ◽

Open Label ◽

Open Label Phase ◽

Phase Ii Clinical Study ◽

Gastric Cancer Patients

An Open label, phase II clinical study to evaluate the efficacy and safety of DPOR/JR2007 in osteoarthritis of knee

Journal of Herbal Medicine ◽

10.1016/j.hermed.2021.100422 ◽

2021 ◽

Vol 26 ◽

pp. 100422

Author(s):

Aasin Maurya ◽

Ankul Suresh Kokate ◽

Kumaraswamy Dussa ◽

Anirudh Tripathi

Keyword(s):

Clinical Study ◽

Phase Ii ◽

Efficacy And Safety ◽

Open Label ◽

Osteoarthritis Of Knee ◽

Open Label Phase ◽

180 An open-label randomized active-controlled phase ii clinical study to assess efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer

10.1136/ijgc-2020-igcs.157 ◽

2020 ◽

Author(s):

Y Yue ◽

H Shen ◽

C Lu ◽

BN Hughes ◽

RL Coleman ◽

...

Keyword(s):

Ovarian Cancer ◽

Clinical Study ◽

Phase Ii ◽

Efficacy And Safety ◽

Open Label ◽

Platinum Resistant ◽